Skip to content
DataLookout
Menu

NCT06212570

KeyScope Study in Uganda

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Sep 1, 2026 to Jan 1, 2027
    • Eligibility criteria expanded, about 8 words
    • Study completion moved earlier from Jun 30, 2028 to Dec 30, 2027
  2. Notable Start date: Jul 1, 2026 to Sep 1, 2026v7
  3. Notable Start date: Apr 1, 2026 to Jul 1, 2026
    • Primary completion pushed from Mar 30, 2027 to Jun 30, 2027
    • Study completion pushed from Mar 30, 2028 to Jun 30, 2028
    v6
  4. Notable Start date: Jan 1, 2026 to Apr 1, 2026
    • Primary completion date: Dec 30, 2026 to Mar 30, 2027
    • Study completion date: Dec 30, 2027 to Mar 30, 2028
    v5
  5. Notable Start date: Oct 1, 2025 to Jan 1, 2026
    • Primary completion date: Jul 30, 2026 to Dec 30, 2026
    • Study completion date: Jul 30, 2027 to Dec 30, 2027
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Jul 1, 2025 to Oct 1, 2025
    • Primary completion date: Apr 30, 2026 to Jul 30, 2026
    • Study completion date: Apr 30, 2027 to Jul 30, 2027
    v3
  2. Notable Primary completion date: Sep 30, 2025 to Apr 30, 2026
    • Start date: Jan 1, 2025 to Jul 1, 2025
    • Study completion date: Sep 30, 2026 to Apr 30, 2027
    v2
  1. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Establish the clinical safety KeySuite
Timeframe: Day of surgery

Secondary (3)

Time to complete surgery
Estimated blood loss
Surgical injuries and adverse events

Arms and interventions

KeySuiteExperimental

The KeyLoop and KeyScope devices will be used to perform intra-abdominal biopsies.

Devices: KeySuite

Sites

1 site in 1 country

  • Uganda Cancer InstituteKampala, Uganda